MENU
+Compare
RPTX
Stock ticker: NASDAQ
AS OF
Jul 25 closing price
Price
$1.56
Change
+$0.01 (+0.65%)
Capitalization
66.91M

RPTX Repare Therapeutics Forecast, Technical & Fundamental Analysis

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer... Show more

RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RPTX with price predictions
Jul 25, 2025

RPTX's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for RPTX turned positive on July 22, 2025. Looking at past instances where RPTX's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 25, 2025. You may want to consider a long position or call options on RPTX as a result. In of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RPTX advanced for three days, in of 229 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 146 cases where RPTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for RPTX moved out of overbought territory on July 11, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 56 cases where RPTX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RPTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RPTX broke above its upper Bollinger Band on July 08, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.535) is normal, around the industry mean (18.028). P/E Ratio (0.000) is within average values for comparable stocks, (59.593). RPTX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.512). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (61.728) is also within normal values, averaging (278.844).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RPTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RPTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
RPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RPTX is expected to report earnings to fall 21.13% to -56 cents per share on August 06

Repare Therapeutics RPTX Stock Earnings Reports
Q2'25
Est.
$-0.56
Q1'25
Missed
by $0.08
Q4'24
Beat
by $0.14
Q3'24
Beat
by $0.06
Q2'24
Beat
by $0.05
The last earnings report on May 13 showed earnings per share of -70 cents, missing the estimate of -62 cents. With 101.58K shares outstanding, the current market capitalization sits at 66.91M.
A.I. Advisor
published General Information

General Information

a company which engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
7210 Frederick-Banting Street
Phone
+1 857 412-7018
Employees
179
Web
https://www.reparerx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CIBN18.50N/A
N/A
Community Investors Bancorp, Inc.
CPYYF2.30N/A
N/A
Centrica Plc
MXGFF3.15N/A
N/A
Maxim Power Corp.
KPLIF0.27N/A
N/A
Keppel Infrastructure Trust
FLMCF0.03N/A
N/A
First Lithium Minerals Corp.

RPTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RPTX has been loosely correlated with INO. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if RPTX jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPTX
1D Price
Change %
RPTX100%
+0.65%
INO - RPTX
51%
Loosely correlated
-2.65%
BCYC - RPTX
48%
Loosely correlated
+1.16%
CADL - RPTX
44%
Loosely correlated
+0.29%
EDIT - RPTX
35%
Loosely correlated
-3.37%
BOLD - RPTX
33%
Poorly correlated
+1.20%
More